Clinical Trials Browser

Phase 2 × Duloxetine Hydrochloride × 90 days × Clear all

NCT04560673 2025-12-31

Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms